Zhao Jinming, Yang Jingxing, Jiao Jian, Wang Xiangdong, Zhao Yan, Zhang Luo
Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Beijing Laboratory of Allergic Diseases and Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
Front Bioeng Biotechnol. 2023 Sep 7;11:1271489. doi: 10.3389/fbioe.2023.1271489. eCollection 2023.
Intranasal administration offers a feasible, non-invasive method of delivering therapeutic drugs to the brain, allowing therapeutic pharmaceuticals to be administered directly to the central nervous system by bypassing the blood-brain barrier. Furthermore, exosomes are naturally occurring cell-derived nanovesicles that can serve as carriers for a variety of chemical compounds. Many studies have focused on artificial exosomes as innovative medication delivery methods. As a result, trans-nasal delivery of artificial exosomes might be employed to treat brain illnesses in a novel method. This review will outline the drug delivery mechanism of artificial extracellular vesicles, emphasize its advantages as a nasal drug carrier, particularly its application as a novel nanocarriers in brain diseases, and focus on its prospective application in chronic inflammatory nose disorders. Finally, artificial exosomes may become a unique drug delivery mode for clinical therapeutic usage.
鼻内给药提供了一种将治疗药物输送到大脑的可行、非侵入性方法,使治疗药物能够绕过血脑屏障直接输送到中枢神经系统。此外,外泌体是天然存在的细胞衍生纳米囊泡,可作为多种化合物的载体。许多研究都集中在将人工外泌体作为创新的药物递送方法。因此,经鼻递送人工外泌体可能会被用于以一种新方法治疗脑部疾病。这篇综述将概述人工细胞外囊泡的药物递送机制,强调其作为鼻腔药物载体的优势,特别是其作为新型纳米载体在脑部疾病中的应用,并关注其在慢性炎症性鼻病中的潜在应用。最后,人工外泌体可能会成为临床治疗用途的一种独特药物递送方式。